Literature DB >> 9712716

Src family tyrosine kinases associate with and phosphorylate CTLA-4 (CD152).

S Miyatake1, C Nakaseko, H Umemori, T Yamamoto, T Saito.   

Abstract

CTLA-4 (CD152) transduces inhibitory signals for T cell activation. Phosphorylation and dephosphorylation of tyrosine residue (Y)-165 in the cytoplasmic region of CTLA-4 play an important role in the signal transduction and in the cell surface. While signaling molecules such as SHP-2 and the p85 subunit of PI3 kinase associate with this tyrosine residue through SH2 domains upon phosphorylation, the adapter complex AP-2 interacts with the same tyrosine when dephosphorylated, leading to clathrin-mediated endocytosis of CTLA-4. We searched for the tyrosine kinase responsible for the phosphorylation of CTLA-4. Src family tyrosine kinases Fyn, Lyn, and Lck associate with CTLA-4 and phosphorylate both Y-165 and Y-182 that are mainly responsible for interaction with Fyn through its SH2 domain. SHP-2 associates with CTLA-4, in a Fyn-dependent manner. Our observations show that src family tyrosine kinases associate with and phosphorylate CTLA-4 and thereby have an important role in the signal transduction and the endocytosis of CTLA-4. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9712716     DOI: 10.1006/bbrc.1998.9191

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

Review 1.  T cell signal transduction and the role of CD7 in costimulation.

Authors:  R Stillwell; B E Bierer
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

Review 2.  CTLA-4 and tolerance: the biochemical point of view.

Authors:  Shunsuke Chikuma; Jeffrey A Bluestone
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

Review 3.  At the bench: preclinical rationale for CTLA-4 and PD-1 blockade as cancer immunotherapy.

Authors:  Andrew M Intlekofer; Craig B Thompson
Journal:  J Leukoc Biol       Date:  2013-04-26       Impact factor: 4.962

Review 4.  Role of the CTLA-4 receptor in T cell activation and immunity. Physiologic function of the CTLA-4 receptor.

Authors:  P Scheipers; H Reiser
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829

5.  SHP-2 expression negatively regulates NK cell function.

Authors:  Amanda K Purdy; Kerry S Campbell
Journal:  J Immunol       Date:  2009-11-13       Impact factor: 5.422

6.  Constitutive clathrin-mediated endocytosis of CTLA-4 persists during T cell activation.

Authors:  Omar S Qureshi; Satdip Kaur; Tie Zheng Hou; Louisa E Jeffery; Natalie S Poulter; Zoe Briggs; Rupert Kenefeck; Anna K Willox; Stephen J Royle; Joshua Z Rappoport; David M Sansom
Journal:  J Biol Chem       Date:  2012-01-19       Impact factor: 5.157

7.  Cytotoxic T lymphocyte antigen 4 (CTLA-4) engagement delivers an inhibitory signal through the membrane-proximal region in the absence of the tyrosine motif in the cytoplasmic tail.

Authors:  C Nakaseko; S Miyatake; T Iida; S Hara; R Abe; H Ohno; Y Saito; T Saito
Journal:  J Exp Med       Date:  1999-09-20       Impact factor: 14.307

Review 8.  CD28 and CTLA-4 coreceptor expression and signal transduction.

Authors:  Christopher E Rudd; Alison Taylor; Helga Schneider
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

9.  PAG/Cbp suppression reveals a contribution of CTLA-4 to setting the activation threshold in T cells.

Authors:  Michal Smida; Clemens Cammann; Slavyana Gurbiel; Nadja Kerstin; Holger Lingel; Sabine Lindquist; Luca Simeoni; Monika C Brunner-Weinzierl; Miloslav Suchanek; Burkhart Schraven; Jonathan A Lindquist
Journal:  Cell Commun Signal       Date:  2013-04-19       Impact factor: 5.712

10.  L1 endocytosis is controlled by a phosphorylation-dephosphorylation cycle stimulated by outside-in signaling by L1.

Authors:  Andrew W Schaefer; Yoshimasa Kamei; Hiroyuki Kamiguchi; Eric V Wong; Iris Rapoport; Tomas Kirchhausen; Carol M Beach; Gary Landreth; Sandra K Lemmon; Vance Lemmon
Journal:  J Cell Biol       Date:  2002-06-24       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.